We are live on ! Find out more
TC

Trilogy Capital Portfolio holdings

AUM $2.58B
1-Year Est. Return 22.97%
This Fund
S&P 500
This Quarter Est. Return
-9.42%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
–
AUM
$743M
AUM Growth
-$64.7M
Cap. Flow
+$15.3M
Cap. Flow %
2.06%
Top 10 Hldgs %
50.59%
Holding
662
New
7
Increased
37
Reduced
82
Closed
529

Top Buys

Rank Stock Value
1
SPIB icon
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
+$12.8M
2
JPME icon
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
+$9.71M
3
QUAL icon
iShares MSCI USA Quality Factor ETF
QUAL
+$8.38M
4
AIVL icon
WisdomTree US AI Enhanced Value Fund
AIVL
+$8.26M
5
MTUM icon
iShares MSCI USA Momentum Factor ETF
MTUM
+$5.53M

Top Sells

Rank Stock Value
1
IGIB icon
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
+$13.2M
2
JHMM icon
John Hancock Multifactor Mid Cap ETF
JHMM
+$11.1M
3
DLS icon
WisdomTree International SmallCap Dividend Fund
DLS
+$4.07M
4
IEI icon
iShares 3-7 Year Treasury Bond ETF
IEI
+$4.05M
5
VTI icon
Vanguard Total Stock Market ETF
VTI
+$2.6M

Sector Composition

Rank Sector Weight
1 Utilities 1.42%
2 Consumer Staples 1%
3 Healthcare 0.65%
4 Technology 0.47%
5 Financials 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIG icon
101
Vanguard Dividend Appreciation ETF
VIG
$111B
$331K 0.04%
3,379
-84
-2% -$8.76K
QQQ icon
102
Invesco QQQ Trust
QQQ
$466B
$328K 0.04%
2,124
+28
+1% +$4.68K
EHC icon
103
Encompass Health
EHC
$11.1B
$322K 0.04%
6,563
-1,726
-21% -$98.2K
ELV icon
104
Elevance Health
ELV
$80.9B
$315K 0.04%
1,199
-253
-17% -$69.6K
HSY icon
105
Hershey
HSY
$34.8B
$308K 0.04%
2,872
-556
-16% -$59.1K
SO icon
106
Southern Company
SO
$107B
$305K 0.04%
6,952
-1,200
-15% -$54.6K
AMGN icon
107
Amgen
AMGN
$198B
$301K 0.04%
1,545
+201
+15% +$39.2K
MSFT icon
108
Microsoft
MSFT
$2.93T
$298K 0.04%
2,932
– –
UHS icon
109
Universal Health Services
UHS
$9.15B
$292K 0.04%
2,504
-511
-17% -$64.2K
META icon
110
Meta Platforms (Facebook)
META
$1.64T
$276K 0.04%
2,104
– –
K
111
DELISTED
Kellanova
K
$252K 0.03%
4,708
-910
-16% -$54.9K
ZBH icon
112
Zimmer Biomet
ZBH
$17.6B
$247K 0.03%
2,451
-485
-17% -$54.5K
GILD icon
113
Gilead Sciences
GILD
$167B
$244K 0.03%
3,903
-3,427
-47% -$240K
CVX icon
114
Chevron
CVX
$373B
$242K 0.03%
2,229
-39
-2% -$4.52K
DGX icon
115
Quest Diagnostics
DGX
$23.3B
$241K 0.03%
2,891
-547
-16% -$51.3K
XOM icon
116
ExxonMobil
XOM
$611B
$225K 0.03%
3,298
+27
+0.8% +$2.12K
KDP icon
117
Keurig Dr Pepper
KDP
$42.1B
$220K 0.03%
+8,581
New +$218K
CPB icon
118
Campbell Soup
CPB
$6.58B
$218K 0.03%
6,622
-1,086
-14% -$41.1K
MCK icon
119
McKesson
MCK
$98.5B
$210K 0.03%
1,904
-313
-14% -$39K
CAH icon
120
Cardinal Health
CAH
$53.5B
$205K 0.03%
4,601
-711
-13% -$37.1K
IWM icon
121
iShares Russell 2000 ETF
IWM
$82.2B
$204K 0.03%
1,523
+3
+0.2% +$448
CIM
122
Chimera Investment
CIM
$1.08B
$187K 0.03%
3,500
-26
-0.7% -$1.42K
STEW
123
SRH Total Return Fund
STEW
$1.76B
$171K 0.02%
16,395
+43
+0.3% +$457
TWO
124
Two Harbors Investment
TWO
$1.27B
$171K 0.02%
3,328
-54
-2% -$3.08K
GCI
125
DELISTED
Gannett Co., Inc
GCI
$171K 0.02%
+20,091
New +$197K
3 4
5
6 7

Similar funds

GFA
Gallagher Fiduciary Advisors Rolling Meadows, Illinois $2.58B AUM 8.97% 1-Year Est. Return
LS
Livforsakringsbolaget Skandia Stockholm, Sweden $2.58B AUM 30.64% 1-Year Est. Return
RG
Rakuten Group Setagaya-Ku, Tokyo, Japan $2.58B AUM 250.19% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
CWS
Confluence Wealth Services Mcmurray, Pennsylvania $2.58B AUM 19.72% 1-Year Est. Return
DCM
Dorsal Capital Management Redwood City, California $2.57B AUM 3.13% 1-Year Est. Return
GWP
Gateway Wealth Partners Appleton, Wisconsin $2.57B AUM 16.81% 1-Year Est. Return
PCM
Palestra Capital Management New York $2.57B AUM 29.93% 1-Year Est. Return

Trilogy Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Trilogy Capital held 662 positions worth $743M, down 8% from $808M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Trilogy Capital's Q4 2018 filing shows 7 new, 37 increased, 82 reduced and 529 closed positions. Its largest new stake was JPMorgan Diversified Return US Mid Cap Equity ETF: 156,277 shares worth $8.93M. The largest sale was iShares 5-10 Year Investment Grade Corporate Bond ETF, an estimated $13.2M.

By sector, the portfolio is most concentrated in Utilities at 1.4% of assets, down from 1.4% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Trilogy Capital's largest Q4 2018 buy was JPMorgan Diversified Return US Mid Cap Equity ETF: 156,277 shares worth $8.93M.
  • Trilogy Capital added most to State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q4 2018, an estimated $12.8M increase.
  • Trilogy Capital's biggest Q4 2018 reduction was iShares 5-10 Year Investment Grade Corporate Bond ETF, cutting an estimated $13.2M.
  • Trilogy Capital fully exited John Hancock Multifactor Mid Cap ETF in Q4 2018, selling an estimated $11.1M.
  • Trilogy Capital's ten largest holdings make up 51% of its $743M portfolio in Q4 2018.
  • Trilogy Capital opened 7 new positions and closed 529 in Q4 2018.
  • Trilogy Capital's portfolio value fell 8% quarter-over-quarter to $743M.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.